Skip to main content
. 2021 Apr 29;11(5):661. doi: 10.3390/biom11050661

Figure 4.

Figure 4

Cardamonin reduces tumor burden in colitis-associated colorectal cancer. (A) Schematic representation showing the time-bound drug treatments for establishing the AOM-induced, DSS-promoted, colitis-associated colorectal cancer model. (B) The effect of cardamonin on tumor number. The number of tumors per animal was counted and represented. (C) The effect of cardamonin on the size of the tumor (in mm). (D) H&E images of all four groups showing the tumor morphology, scale bar = 100 µm.